Back to Search

MATTHEW KEEFER, MD

MD

Anesthesiology Physician

NPI: 1649236258IndividualAccepts Medicare

Specialties, Licenses & Credentials

Anesthesiology PhysicianPrimary

Anesthesiology

Code: 207L00000X

01033497A(IN)

CMS Specialties

PrimaryANESTHESIOLOGY

Education

INDIANA UNIVERSITY SCHOOL OF MEDICINE

Class of 1983

Research & Publications (20)

Effects of modified short-leg walkers on ground reaction force characteristics.
PMID 18701198·Clin Biomech (Bristol)·2008
8-other
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
PMID 19298995·Virology·2009
8-other
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
PMID 18996425·Vaccine·2009
3-trial
Transporting juvenile salmonids around dams impairs adult migration.
PMID 19263886·Ecol Appl·2008
7-preclinical
Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.
PMID 17145123·Vaccine·2007
7-preclinical
HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime.
PMID 17868958·Vaccine·2007
7-preclinical
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
PMID 17106277·J Acquir Immune Defic Syndr·2007
3-trial
Hispanic women's perceptions of patient-centeredness during prenatal care: a mixed-method study.
PMID 16336373·Birth·2005
4-observational
Making good use of online case study materials.
PMID 16190282·Sci Eng Ethics·2005
6-review
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
PMID 16136469·J Infect Dis·2005
3-trial
Establishment of an alternative intracellular cytokine staining assay for HIV/AIDS clinical studies.
PMID 15620394·J Virol Methods·2005
8-other
Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
PMID 15295694·J Infect Dis·2004
3-trial
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
PMID 15031791·J Infect Dis·2004
3-trial
Safety profile of recombinant canarypox HIV vaccines.
PMID 14741163·Vaccine·2004
3-trial
Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
PMID 12798637·Vaccine·2003
3-trial
Constrictive pericarditis caused by candida glabrata in an immunocompetent patient: case report and review of literature.
PMID 12238580·Scand J Infect Dis·2002
5-case
Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.
PMID 11873074·J Acquir Immune Defic Syndr·2002
3-trial
Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production.
PMID 11348664·Immunol Lett·2001
3-trial
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
PMID 11311997·Vaccine·2001
3-trial
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
PMID 11294665·J Infect Dis·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1000 E MAIN ST
DANVILLE, IN 46122

Location

Practice Location

1000 E MAIN ST, DANVILLE, IN
(317) 567-2180

Quick Facts

NPI
1649236258
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
43
Publications
20

Are you this provider?

Claim Your Profile